AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Aug 8, 2012
30071_dirs_2012-08-08_52373f5f-9dcd-4a55-8fa0-0f6036cd920c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-07
Reporting Person: Douglas Robert Andrew (COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-07 | ResMed Common Stock | M | 23333 | $23.095 | Acquired | 81556.968 | Direct |
| 2012-08-07 | ResMed Common Stock | S | 23333 | $36.00 | Disposed | 58223.9682 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-07 | ResMed Common Stock Options | $23.095 | M | 23333 | Disposed | 2013-11-10 | ResMed Common Stock (23333) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 annually.
F2: Transaction executed pursuant to 10b5-1.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29